OK SB 2024
died on adjournmentPharmaceutical products; requiring publishing of certain information by manufacturers. Effective date.
Oklahoma · 2026 Regular Session · upper
Quick answers
Did OK SB 2024 pass?
No. OK SB 2024 died when the 2026 Regular Session adjourned without final action on it. Bills that die this way are sometimes reintroduced in a later session. Latest recorded action (2026-02-03): Second Reading referred to Business and Insurance
What is OK SB 2024 about?
OK SB 2024 is a bill in the 2026 Regular Session titled “Pharmaceutical products; requiring publishing of certain information by manufacturers. Effective date.”.
Who sponsors OK SB 2024?
Deevers is the primary sponsor of OK SB 2024.
- Introduced
- 2026-02-02
- Latest action
- 2026-02-03 — Second Reading referred to Business and Insurance
- Bill type
- bill
- Last updated
- —
Sponsors
- Deeversprimary
Committees
Not provided by source.
Action timeline
2026-02-02
First Reading
introduction,reading-1
2026-02-02
Authored by Senator Deevers
2026-02-03
Second Reading referred to Business and Insurance
reading-2,referral-committee
Versions
- IntroducedCompare
Documents
Votes
Not provided by source.
Related bills
No related bills recorded for this bill.
Official source
Attribution
Data from openstates_bulk_csv, retrieved 2026-07-24T05:30:20.811026Z
Inspect retained evidence for changes recorded after evidence tracking began:
Use this data
Every field on this page is available from the free public API — no key or licence required. Fetch this bill as JSON: GET /api/v1/bills?jurisdiction=OK&identifier=SB 2024. See the API docs or the MCP server for AI assistants.
Known limitations
- Sponsor party and chamber affiliation are not yet captured by this API.
- Committee referrals are not yet captured.
See the methodology page for data sources and limitations.